Bios Partners — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Trefoil Therapeuticstrefoiltherapeutics.cominApr 2025✓ verified
Trefoil Therapeutics is a clinical-stage biotechnology company developing therapeutic agents for corneal diseases.
BiotechHealthtechMedical DevicesSan Diego, US
David Eveleth(Executive Officer, Director)inSchalon Newton(Executive Officer)in
BoardChristy Shaffer(Director)inRalph Bradshaw(Director)
Board seatStella Robertson· per SEC Form D
Co-investorsExSight VenturesHatteras Venture PartnersSolasta VenturesAccess BiotechnologyCorrelation VenturesFemHealth Ventures+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.







